| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | BIX-01294 | CTRPv2 | pan-cancer | AAC | -0.09 | 0.02 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.21 | 0.02 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.084 | 0.02 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.086 | 0.03 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.091 | 0.03 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | -0.095 | 0.03 |